Visit our booth at "OTS"
📅October 11-14, 2026
📍Denver, CO (USA) - Booth #29
As a leading therapeutic oligonucleotide manufacturer (CDMO), Eurogentec offers comprehensive end-to-end solutions for the development and manufacturing of high-quality oligonucleotides for innovative therapies. Our state-of-the-art facilities and team of experts ensure efficient and reliable production, from preclinical to clinical phases.
Learn more about our GMP Oligo manufacturing & CMC Services :
About the event :
The 22nd Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) brings together leading researchers and industry experts to advance the field of oligonucleotide therapeutics. This premier event fosters collaboration and knowledge sharing, covering a wide range of topics, including antisense, siRNA, immunostimulatory, and aptamer technologies, as well as RNA/DNA editing and mRNA therapeutics.
For more information, visit the event website.
Book a meeting with our team today :
Muriel CRAYNEST
Business Development Manager Proteomics
Thomas POLLENUS
Market Strategy Manager
Don't miss this opportunity to talk with our experts, schedule a meeting today to avoid the line.
Let's advance science together !